|
Apr 22
|
Oncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at IDDST-Europe 2025 Conference in Stockholm
|
|
Apr 16
|
Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023
|
|
Feb 13
|
Oncotelic CEO Vuong Trieu to Present Groundbreaking Research on Transforming Growth Factor Beta 2 (TGFB2) at SWCR 2025 Conference
|
|
Dec 31
|
Oncotelic Therapeutics Implements PDAOAI Platform
|
|
Jul 29
|
Product Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence
|
|
May 30
|
ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING
|
|
Nov 28
|
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.
|
|
Nov 15
|
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results
|
|
Aug 25
|
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023
|